Efficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 10 mg in Korean Adults With Type 2 Diabetes: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase III Trial.
https://www.medspoke.co/channel_journal?id=804&tap_id=17722